GSK has announced that Exdensur (depemokimab) has received marketing authorisation from the UK MHRA for use in certain asthma and chronic rhinosinusitis with nasal polyps patients...
Anglo American and Teck Resources have received approval from the Government of Canada under the Investment Canada Act for their proposed merger of equals...
Manx Financial has announced the exercise of Restricted Stock Units over 2,072,500 new ordinary shares at nil cost. The share issues relate to vested awards granted in November 2023 and include allocations to directors and a PDMR, with admission to trading on AIM expected on 23 December 2025...
The AIM listed finance provider recorded higher new business origination, an expanded lending book, and increased profit before tax, alongside lower arrears and write-offs, supporting confidence that full year performance will be in line with market guidance...
GSK has announced that Exdensur (depemokimab) has received marketing authorisation from the UK MHRA for use in certain asthma and chronic rhinosinusitis with nasal polyps patients...
Anglo American and Teck Resources have received approval from the Government of Canada under the Investment Canada Act for their proposed merger of equals...
Manx Financial has announced the exercise of Restricted Stock Units over 2,072,500 new ordinary shares at nil cost. The share issues relate to vested awards granted in November 2023 and include allocations to directors and a PDMR, with admission to trading on AIM expected on 23 December 2025...
The AIM listed finance provider recorded higher new business origination, an expanded lending book, and increased profit before tax, alongside lower arrears and write-offs, supporting confidence that full year performance will be in line with market guidance...
